Treatment of MRSA Infection.

Tatsuya Beppu, Mamoru Tomishige, Fusao Naruto, Junichi Arima, Yoshiyuki Matsumoto, Takuya Tamaru, Toshiyuki Kawasaki, Masahiro Kina, Kenichiro Shibata(Japanese Red Cross Society, Japan)

Orthopedics & Traumatology

January 1, 1995

10.5035/nishiseisai.44.50

Cited by 1

Related Papers

Synergistic Effect of Nod1 and Nod2 Agonists with Toll-Like Receptor Agonists on Human Dendritic Cells To Generate Interleukin-12 and T Helper Type 1 Cells

|Infection and Immunity|2005|361

Influence of length on cytotoxicity of multi-walled carbon nanotubes against human acute monocytic leukemia cell line THP-1 <i>in vitro</i> and subcutaneous tissue of rats <i>in vivo</i>

|Molecular BioSystems|2005|356

<i>Saccharomyces cerevisiae</i>‐ and <i>Candida albicans</i>‐Derived Mannan Induced Production of Tumor Necrosis Factor Alpha by Human Monocytes in a CD14‐ and Toll‐Like Receptor 4‐Dependent Manner

|Microbiology and Immunology|2002|296

Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human

|Cellular Microbiology|2004|200

Relationship between Structures and Biological Activities of Mycoplasmal Diacylated Lipopeptides and Their Recognition by Toll-Like Receptors 2 and 6

|Infection and Immunity|2004|176